These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 2139036)
21. Transforming growth factor beta 1: importance of glycosylation and acidic proteases for processing and secretion. Sha X; Brunner AM; Purchio AF; Gentry LE Mol Endocrinol; 1989 Jul; 3(7):1090-8. PubMed ID: 2677679 [TBL] [Abstract][Full Text] [Related]
22. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta. Odekon LE; Blasi F; Rifkin DB J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064 [TBL] [Abstract][Full Text] [Related]
23. Identification and analysis of discrete functional domains in the pro region of pre-pro-transforming growth factor beta 1. Sha X; Yang L; Gentry LE J Cell Biol; 1991 Aug; 114(4):827-39. PubMed ID: 1869589 [TBL] [Abstract][Full Text] [Related]
24. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. Schultz-Cherry S; Ribeiro S; Gentry L; Murphy-Ullrich JE J Biol Chem; 1994 Oct; 269(43):26775-82. PubMed ID: 7929413 [TBL] [Abstract][Full Text] [Related]
25. Structure and activation of the large latent transforming growth factor-beta complex. Nunes I; Munger JS; Harpel JG; Nagano Y; Shapiro RL; Gleizes PE; Rifkin DB Int J Obes Relat Metab Disord; 1996 Mar; 20 Suppl 3():S4-8. PubMed ID: 8680476 [TBL] [Abstract][Full Text] [Related]
26. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1. Saharinen J; Taipale J; Keski-Oja J EMBO J; 1996 Jan; 15(2):245-53. PubMed ID: 8617200 [TBL] [Abstract][Full Text] [Related]
27. Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1: effects on secretion and bioactivity. Brunner AM; Lioubin MN; Marquardt H; Malacko AR; Wang WC; Shapiro RA; Neubauer M; Cook J; Madisen L; Purchio AF Mol Endocrinol; 1992 Oct; 6(10):1691-700. PubMed ID: 1448117 [TBL] [Abstract][Full Text] [Related]
28. Characterization of the binding of transforming growth factor-beta 1, -beta 2, and -beta 3 to recombinant beta 1-latency-associated peptide. Miller DM; Ogawa Y; Iwata KK; ten Dijke P; Purchio AF; Soloff MS; Gentry LE Mol Endocrinol; 1992 May; 6(5):694-702. PubMed ID: 1603080 [TBL] [Abstract][Full Text] [Related]
29. Generation of transforming growth factor-alpha from the cell surface by an O-glycosylation-independent multistep process. Teixido J; Wong ST; Lee DC; Massagué J J Biol Chem; 1990 Apr; 265(11):6410-5. PubMed ID: 2318860 [TBL] [Abstract][Full Text] [Related]
30. Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Khalil N; Corne S; Whitman C; Yacyshyn H Am J Respir Cell Mol Biol; 1996 Aug; 15(2):252-9. PubMed ID: 8703482 [TBL] [Abstract][Full Text] [Related]
31. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. Schultz-Cherry S; Murphy-Ullrich JE J Cell Biol; 1993 Aug; 122(4):923-32. PubMed ID: 8349738 [TBL] [Abstract][Full Text] [Related]
32. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Grainger DJ; Wakefield L; Bethell HW; Farndale RW; Metcalfe JC Nat Med; 1995 Sep; 1(9):932-7. PubMed ID: 7585220 [TBL] [Abstract][Full Text] [Related]
33. Activation of human platelet-derived latent transforming growth factor-beta 1 by human glioblastoma cells. Comparison with proteolytic and glycosidic enzymes. Huber D; Fontana A; Bodmer S Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):165-73. PubMed ID: 1830205 [TBL] [Abstract][Full Text] [Related]
34. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. Flaumenhaft R; Abe M; Mignatti P; Rifkin DB J Cell Biol; 1992 Aug; 118(4):901-9. PubMed ID: 1380001 [TBL] [Abstract][Full Text] [Related]
35. Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta1 from the extracellular matrix of growth plate chondrocytes. Pedrozo HA; Schwartz Z; Robinson M; Gomes R; Dean DD; Bonewald LF; Boyan BD Endocrinology; 1999 Dec; 140(12):5806-16. PubMed ID: 10579347 [TBL] [Abstract][Full Text] [Related]
36. Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor beta that can be activated by neural crest cell proteolysis. Brauer PR; Yee JA Dev Biol; 1993 Jan; 155(1):281-5. PubMed ID: 8416842 [TBL] [Abstract][Full Text] [Related]
37. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708 [TBL] [Abstract][Full Text] [Related]
38. An improved recombinant mammalian cell expression system for human transforming growth factor-beta2 and -beta3 preparations. Zou Z; Sun PD Protein Expr Purif; 2006 Nov; 50(1):9-17. PubMed ID: 16901717 [TBL] [Abstract][Full Text] [Related]
39. Active transforming growth factor-beta in human melanoma cell lines: no evidence for plasmin-related activation of latent TGF-beta. Bizik J; Felnerova D; Grofova M; Vaheri A J Cell Biochem; 1996 Jul; 62(1):113-22. PubMed ID: 8836880 [TBL] [Abstract][Full Text] [Related]